PSTX - Poseida Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PSTX is currently covered by 4 analysts with an average price target of $26.91. This is a potential upside of $17.41 (183.26%) from yesterday's end of day stock price of $9.5.

Poseida Therapeutics's activity chart (see below) currently has 12 price targets and 24 ratings on display. The stock rating distribution of PSTX is 78.57% BUY and 21.43% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 4.17% with an average time for these price targets to be met of 232 days.

Highest price target for PSTX is $9, Lowest price target is $2.

Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 02-Dec-2024. First documented stock forecast 17-Aug-2020.

Best performing analysts who are covering PSTX - Poseida Therapeutics:

Edward Tenthoff Tyler Van Buren Jennifer Kim Justin Zelin

Currently out of the existing stock ratings of PSTX, 11 are a BUY (78.57%), 3 are a HOLD (21.43%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

$10

4 months 7 days ago
(02-Dec-2024)

1/6 (16.67%)

$7.15 (250.88%)

928

Hold

$40

4 months 14 days ago
(26-Nov-2024)

0/1 (0%)

$31.16 (352.49%)

Buy

$17

1 years 8 months ago
(09-Aug-2023)

0/2 (0%)

$12.68 (293.52%)

Buy

$30

$27.62 (1160.50%)

$30

4 years 1 months 16 days ago
(25-Feb-2021)

0/3 (0%)

$18.66 (170.66%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PSTX (Poseida Therapeutics) average time for price targets to be met?

On average it took 232 days on average for the stock forecasts to be realized with a an average price target met ratio 4.17

Which analyst has the current highest performing score on PSTX (Poseida Therapeutics) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on PSTX (Poseida Therapeutics) with a proven track record?

JUSTIN ZELIN

Which analyst has the most public recommendations on PSTX (Poseida Therapeutics)?

Edward Tenthoff works at PIPER SANDLER and has 5 price targets and 4 ratings on PSTX

Which analyst is the currently most bullish on PSTX (Poseida Therapeutics)?

Tyler Van Buren with highest potential upside - $27.62

Which analyst is the currently most reserved on PSTX (Poseida Therapeutics)?

Edward Tenthoff with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?